- Dulaglutid2016 | Second Faculty of Medicine
- Any expectations from the more powerful dulaglutide?2022 | First Faculty of Medicine
- Dulaglutide2018 | First Faculty of Medicine
- Komentář ke studii (Uspořádání a výchozí charakteristiky účastníků kardiovaskulární studie REWIND s dulaglutidem)2018 | First Faculty of Medicine
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial2019 | Publication without faculty affiliation
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial2019 | Publication without faculty affiliation
- Dulaglutid v léčbě obézních diabetiků 2. typu2022 | First Faculty of Medicine
- Dulaglutide and Incident Atrial Fibrillation or Flutter in patients with type 2 Diabetes; a post-hoc analysis from the REWIND Randomized Trial2022 | Publication without faculty affiliation
- Dulaglutide and Cardiovascular and Heart Failure Outcomes in Patients With and Without Heart Failure: A Post-hoc Analysis from the REWIND Randomized Trial2022 | Publication without faculty affiliation
- The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial2020 | Publication without faculty affiliation
- Promising molecules for treatment of hyperglycemia in patients with type 2 diabetes2016 | Second Faculty of Medicine
- Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin2021 | Publication without faculty affiliation
- Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide2018 | Publication without faculty affiliation
- Inkretinová analoga2018 | First Faculty of Medicine
- Výsledky a praktické výstupy studie REWIND2019 | Publication without faculty affiliation
- Dalaglutid: průlom v injekční léčbě pacientů s diabetem2018 | Publication without faculty affiliation
- The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia2022 | First Faculty of Medicine